Reading time: 4 minutes Aishat Motolani Cetuximab, Panitumumab, Tucatinib, and Ipilimumab, just to name a few, are examples of drugs approved for metastatic colorectal cancer (mCRC) over the past two decades. However, due to the poor outcomes of some of these drugs in mCRC patients, researchers are exploring new treatment combinations to optimize efficacy. This... Continue Reading →
Reading time: 6 minutes Spencer Maingi Identifying IDH mutations and their function In 2008, researchers studying brain tumors discovered something surprising. Patients with “secondary glioblastoma”, a uniformly lethal cancer that arises from a prior, less aggressive brain tumor (“low-grade glioma”), frequently had mutations in their tumor in the gene isocitrate dehydrogenase 1 (IDH1).1 Even more... Continue Reading →
Reading Time: 4 minutes Chris Wang The liver is a uniquely important organ in your body. It filters all of your blood, produces bile to digest foods/carry away waste, and can even regenerate even after 90% has been removed. Unfortunately, the liver is also an organ where many cancers metastasize to. Colorectal cancer in particular... Continue Reading →
OncoBites 